Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study
Year: 2017
Type: article
Study design: Clinical Trial
Authors: Arinobu Tojo, Taiichi Kyo, Kazuhito Yamamoto, Hirohisa Nakamae, Naoto Takahashi, Yukio Kobayashi, Tetsuzo Tauchi, Shinichiro Okamoto, Koichi Miyamura, Kiyohiko Hatake, Hiromi Iwasaki, Itaru Matsumura, Noriko Usui, Tomoki Naoe, Meera Tugnait, Narayana I. Narasimhan, Stephanie Lustgarten, Heinrich Farin, Frank Haluska, Kazuma Ohyashiki
Institutions: Institute of Medical Science, The University of Tokyo, The University of Tokyo, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Aichi Cancer Center Hospital, Osaka City University Hospital, Akita University Hospital, National Cancer Center Hospital, Tokyo Medical University Hospital, Keio University Hospital, Japanese Red Cross Nagoya Daiichi Hospital, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Kyushu University Hospital, Kindai University Hospital, The Jikei University West Medical Center, National Hospital Organization, Nagoya Medical Center, ARIAD Pharmaceuticals (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2608124271